Skip to main
ARWR
ARWR logo

Arrowhead Pharmaceuticals (ARWR) Market Capitalization Overview

Market Cap: $2.19B as of Jun 30, 2025

$2.19B
Past Month-$37.29M (1.68%)
As of Jun 30, 2025, Arrowhead Pharmaceuticals (ARWR) has a market capitalization of $2.19B. Over the past 30 days, its market cap has increased by 17.48%, while in the last 12 months, it has decreased by -6.73%.

Market capitalization represents the total value of Arrowhead Pharmaceuticals as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

Arrowhead Pharmaceuticals (ARWR) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of Arrowhead Pharmaceuticals (ARWR) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Arrowhead Pharmaceuticals (ARWR) Market Cap History

DateMarket CapChange
Jun 2, 2025$2.27B+17.48%
May 1, 2025$1.93B+15.03%
Apr 1, 2025$1.68B-24.95%
Mar 3, 2025$2.24B-4.72%
Feb 3, 2025$2.35B-4.14%
Jan 2, 2025$2.45B-25.40%

Arrowhead Pharmaceuticals (ARWR) End of Year Market Cap History

DateMarket CapChange
2025$2.19B-6.73%
2024$2.34B-28.84%
2023$3.29B-23.54%
2022$4.30B-37.96%
2021$6.94B-12.11%
2020$7.89B

FAQs About Arrowhead Pharmaceuticals (ARWR) Market Cap

As of Jun 30, 2025, the market capitalization of Arrowhead Pharmaceuticals (ARWR) is $2.19B. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Arrowhead Pharmaceuticals’s market capitalization has decreased by -1.68%, changing from $2.22B to $2.19B as of Jun 30, 2025.

In the last 3 months, Arrowhead Pharmaceuticals’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, Arrowhead Pharmaceuticals’s market capitalization decreased from $3.29B in January to $2.34B in December, reflecting a -28.84% change.

In the past five years, Arrowhead Pharmaceuticals (ARWR) has had a compound annual growth rate (CAGR) of -21.57% in market capitalization. This means its market cap has shrunk at an average rate of -21.57% per year.

Arrowhead Pharmaceuticals (ARWR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.